MSK CME/X
Aug 2, 2025, 18:05
MSK Cancer Center CME: Expert Insights on Benign Hematology, Hemostasis and Thrombosis
MSK (Memorial Sloan Kettering Cancer Center) CME posted on X:
”Join us MSK Cancer Center for a state-of-the-art update in benign hematology, featuring expert-led discussions on complex hemostasis and thrombosis management, advances in hemolytic anemias, hematologic complications of cellular and immunotherapies, and emerging treatment strategies. Learn more here.”
Stay updated with Hemostasis Today.
-
Dec 21, 2025, 06:41Architha Reddy on Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
-
Dec 21, 2025, 06:28Siddarth Raajasekar on Neopterin Association with Stroke and Carotid Endarterectomy
-
Dec 20, 2025, 18:30Kate Scrivener on Cochrane Review: 2025 Ends With a Big Milestone!
-
Dec 20, 2025, 18:19A CT-Based Clinical Overview from Muhammad Abubakar: Stroke and Intracranial Hemorrhages
-
Dec 20, 2025, 18:15Shekher Bose on AstraZeneca’s Voluntary Withdrawal of Andexxa
-
Dec 20, 2025, 17:10Mina Adel Nagi on the Future of ESR Testing with HORIBA’s CoRA Technology
-
Dec 20, 2025, 17:02Osman Farhan on Participation in 2nd TIF Workshop for Thalassemia and Sickle Cell Warriors
-
Dec 20, 2025, 16:50Geert Verheyden on Advancing Stroke Rehabilitation Through Collaboration and Innovation
-
Dec 20, 2025, 16:26Dirk Sibbing on Antithrombotic Drugs for ACS in Women